about
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts.Addressing heterogeneity of individual blood cancers: the need for single cell analysis.The fludarabine, cytarabine, and granulocyte colony-stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline-based therapy for the treatment of acute myeloid leukemia for patients with pre-existing cardiac disease.Treatment of older patients with acute myeloid leukemia (AML): revised Canadian consensus guidelines.Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1.Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening.A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191.Persistent cytogenetic abnormalities in patients undergoing intensive chemotherapy for acute myeloid leukemiaIncremental value of the bone marrow trephine biopsy in detecting residual leukemia following treatment for Acute Myeloid Leukemia
P50
Q33431778-611A8182-8566-4601-A20C-0150A3857404Q35859212-11A70CC5-4370-4784-B6D4-C67BCE3C727CQ38808876-8B513065-48AA-4D38-BFC0-621BFBAF24B4Q40827250-5796944F-EBB6-4AB6-B9EA-FE01063B213EQ41265804-E4ADE190-DDF7-44D9-B4BE-468A4FC6059DQ42181641-C56F4F62-BE36-420B-91AC-68D84B8C118BQ48307002-245EF6FA-C6FD-49C0-BE98-C3566B128CC0Q53817434-0E564B5A-C057-46BD-A98A-81A63E2E1577Q88142762-FDDDE518-DA78-4913-B10A-6614092C8B09Q89253986-D899C256-2FB4-4610-AC19-A5499A97D7D0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Irwindeep Sandhu
@ast
Irwindeep Sandhu
@en
Irwindeep Sandhu
@es
Irwindeep Sandhu
@nl
type
label
Irwindeep Sandhu
@ast
Irwindeep Sandhu
@en
Irwindeep Sandhu
@es
Irwindeep Sandhu
@nl
prefLabel
Irwindeep Sandhu
@ast
Irwindeep Sandhu
@en
Irwindeep Sandhu
@es
Irwindeep Sandhu
@nl
P106
P1153
6603104340
P31
P496
0000-0001-9407-6265